Arrivent BioPharma, Inc. (AVBP)
26.73
-0.27
(-1.00%)
USD |
NASDAQ |
May 22, 16:00
26.74
+0.01
(+0.04%)
After-Hours: 20:00
Arrivent BioPharma EPS Diluted (Quarterly) : -0.9612 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ocugen, Inc. | -0.0586 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Agenus, Inc. | 1.023 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -43.32M |
| Total Expenses (Quarterly) | 43.32M |
| Enterprise Value | 777.49M |
| Earnings Yield | -13.21% |
| Normalized Earnings Yield | -13.21 |